» Articles » PMID: 34959658

Exosome MicroRNAs in Metabolic Syndrome As Tools for the Early Monitoring of Diabetes and Possible Therapeutic Options

Overview
Publisher MDPI
Specialty Chemistry
Date 2021 Dec 28
PMID 34959658
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are nano-sized extracellular vesicles produced and released by almost all cell types. They play an essential role in cell-cell communications by delivering cellular bioactive compounds such as functional proteins, metabolites, and nucleic acids, including microRNA, to recipient cells. Thus, they are involved in various physio-pathological conditions. Exosome-miRNAs are associated with numerous diseases, including type 2 diabetes, a complex multifactorial metabolic disorder linked to obesity. In addition, exosome-miRNAs are emerging as essential regulators in the progression of diabetes, principally for pancreatic β-cell injury and insulin resistance. Here, we have clustered the recent findings concerning exosome-miRNAs associated with β-cell dysfunction to provide a novel approach for the early diagnosis and therapy of diabetes.

Citing Articles

Special Issue "Adipose Tissue Diseases: Physiopathology, Molecular Mechanism, Diagnosis, and Treatment".

Cannataro R, Michelini S, Cione E Int J Mol Sci. 2025; 26(5).

PMID: 40076692 PMC: 11900491. DOI: 10.3390/ijms26052068.


Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease.

Malaguarnera M, Cauli O, Cabrera-Pastor A Biomolecules. 2025; 15(2).

PMID: 40001534 PMC: 11853251. DOI: 10.3390/biom15020231.


Analysis of Exosomal miRNA and Hepatic mRNA Expression in the Dysregulation of Insulin Action in Perimenopausal Mice.

Yang Y, Chen Y, Liu C, Wang S, Zhao Y, Cao W J Diabetes Res. 2025; 2025():6251747.

PMID: 39823117 PMC: 11737908. DOI: 10.1155/jdr/6251747.


Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion.

Chen Q, Chen J, Liu Y, Qi S, Huang L Extracell Vesicles Circ Nucl Acids. 2024; 4(3):502-517.

PMID: 39698026 PMC: 11648477. DOI: 10.20517/evcna.2023.32.


Identification of Specific microRNAs in Adipose Tissue Affected by Lipedema.

Cione E, Michelini S, Abrego-Guandique D, Vaia N, Michelini S, Puleo V Curr Issues Mol Biol. 2024; 46(11):11957-11974.

PMID: 39590304 PMC: 11592672. DOI: 10.3390/cimb46110710.


References
1.
Fu Q, Jiang H, Wang Z, Wang X, Chen H, Shen Z . Injury factors alter miRNAs profiles of exosomes derived from islets and circulation. Aging (Albany NY). 2018; 10(12):3986-3999. PMC: 6326691. DOI: 10.18632/aging.101689. View

2.
TRAMS E, Lauter C, Salem Jr N, Heine U . Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta. 1981; 645(1):63-70. DOI: 10.1016/0005-2736(81)90512-5. View

3.
Kowal J, Arras G, Colombo M, Jouve M, Morath J, Primdal-Bengtson B . Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016; 113(8):E968-77. PMC: 4776515. DOI: 10.1073/pnas.1521230113. View

4.
Zhao X, Mohan R, Ozcan S, Tang X . MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem. 2012; 287(37):31155-64. PMC: 3438947. DOI: 10.1074/jbc.M112.362632. View

5.
Ou C, Sun Z, Li X, Li X, Ren W, Qin Z . MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. Cancer Lett. 2017; 399:53-63. DOI: 10.1016/j.canlet.2017.04.011. View